United Therapeutics Corporation · NASDAQ:UTHR

Rothblatt Martine A sold 9,500 United Therapeutics Corporation shares (Form 4)

Traded Aug 10, 2026 · Filed Aug 11, 2026

On Aug 10, 2026, Rothblatt Martine A (Director, Chairperson & CEO) sold 9,500 United Therapeutics Corporation shares at an average US$530.11 for US$5.04M under a trading plan, leaving 324,443 shares. Filed Aug 11, 2026 (Form 4).

Sold
9,500 shares
Price
US$530.11 average (US$523.95 to US$538.86)
Value
US$5.04M
Holding after
324,443 shares (held indirectly)
Trading plan
Yes (Made under a plan set in advance)
Role
Director, Chairperson & CEO

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Aug 10, 2026Common StockOption exercise9,500US$135.42333,943Indirect
Aug 10, 2026Common StockSale578US$523.95333,365Indirect
Aug 10, 2026Common StockSale582US$524.86332,783Indirect
Aug 10, 2026Common StockSale120US$525.73332,663Indirect
Aug 10, 2026Common StockSale722US$527.38331,941Indirect
Aug 10, 2026Common StockSale731US$528.40331,210Indirect
Aug 10, 2026Common StockSale1,050US$529.27330,160Indirect
Aug 10, 2026Common StockSale3,027US$530.26327,133Indirect
Aug 10, 2026Common StockSale640US$531.15326,493Indirect
Aug 10, 2026Common StockSale459US$532.28326,034Indirect
Aug 10, 2026Common StockSale391US$533.21325,643Indirect
Aug 10, 2026Common StockSale286US$535.27325,357Indirect
Aug 10, 2026Common StockSale514US$536.23324,843Indirect
Aug 10, 2026Common StockSale186US$537.91324,657Indirect
Aug 10, 2026Common StockSale214US$538.86324,443Indirect

Source

View original at SEC

Related